However, the second study used clinical samples from patients enrolled in other asthma studies, as well as immortalized human tissue lines, to demonstrate that airway epithelial PON2 expression is decreased in participants with comorbid obesity and asthma and associated with increased mitochondrial ROS after an oxidant challenge. The gene discussed is PON2; the disease is obesity disorder.